Opinion

Micron Devices, LLC

Court
United States Bankruptcy Court, S.D. Florida.
Filed
May 20, 2021
Cited by
0 cases
Authority
More cited than 30.0%

The opinion

PRR,

op Jf A

sg Yhagl”'¢

a Se, 5

x % □ ae □

ORDERED in the Southern District of Florida on May 20, 2021.

frau YN Die

Laurel M. Isicoff

Chief United States Bankruptcy Judge

Tagged Opinion

Do not publish

UNITED STATES BANKRUPTCY COURT

SOUTHERN DISTRICT OF FLORIDA

MIAMI DIVISION

www.fisb.uscourts.gov

In re: Case No. 20-23359-LMI

MICRON DEVICES, LLC, Chapter 11

Debtor.

ee

ORDER GRANTING TRUSTEE’S MOTION FOR APPROVAL OF SETTLEMENT

AGREEMENT (ECF #234) AND APPROVING SETTLEMENT AGREEMENT

THIS CAUSE having come before the Court for evidentiary hearing on April

30, 2021 and May 7, 2021 (the “Evidentiary Hearing”) upon the Trustee’s Motion

For Approval Of The Settlement Agreement Entered Into By The Subchapter V

Chapter 11 Trustee, Kennedy Lewis Investment Management, LLC And Stimwave

Technologies, Inc. (the “9019 Motion”) (ECF #234) filed by Tarek Kiem, the

Subchapter V Chapter 11 Trustee (the “Trustee”), pursuant to Fed. R. Bankr. P.

Rule 9019, seeking approval of Settlement Agreement filed with the Court on

April 20, 2021 (the “Settlement Agreement”) (ECF #256, Trustee Ex. 2), as revised

by the redlined modifications in the Trustee’s Exhibit 56 and by the modifications

announced on the record at the Evidentiary Hearing and reflected at the end of

this Order. The Court, having reviewed the 9019 Motion, Settlement Agreement,

the Objections filed by Maryam Amiri, Brandyn J. Perryman, Patrick Larson,

Marlene Pena, Ronald Perryman, Gary Perryman, Micron Medical Corporation

(“MMC”), Luis Fernandez, Micron Devices, LLC (“Debtor”), and Cobalt Capital,

LLC (ECF ##269, 270, 271, 272, 273, 274, 283, 289, 290, 291, 312, 317, 322)

(“Objections”), all evidence admitted by the Court at the Evidentiary Hearing,

including the Declaration of the Trustee (“Trustee Dec.”) (ECF #310) and

Supplemental Declaration of the Trustee1 (“Trustee Suppl. Dec.”) (ECF #321), the

Declaration of Jeff Goldberg (“Goldberg Dec.”) (ECF #300), the Certification of the

Records Custodian of Stimwave Technologies Inc. (ECF #301), the Declaration of

David Kho (“Kho Dec.”) (ECF #299), the Exhibits 1-62 submitted by the Trustee

(“Trustee Ex.”) (ECF ##302, 303, 304, 305, 306, 307, 308, 309, 320), the Exhibits

1, 2, and 20 submitted by the Debtor (“Debtor Ex.”) (ECF ##356, 361) the

Exhibits 2-4, 6-9, 11, 19-26, and 27-29 submitted by MMC (“MMC Ex.”) (ECF

##315, 355), the live testimony of the Trustee, Jeff Goldberg, David Kho, Sanjay

1 The Supplemental Declaration of the Trustee was admitted with the exception of the paragraphs

25 through 42, which related to the Trustee’s Exhibits 63 and 64, which were excluded from

evidence.

Gupta, Pamela Beidleman, and Brandyn Perryman, and all arguments presented

by the parties, and having taken judicial notice of the procedural record and all

pleadings filed in this proceeding, pursuant to Fed. R. Bankr. P. 7052, makes

the following findings of fact and conclusions of law in support of the Court

GRANTING the 9019 Motion and OVERRULING the Objections.2

FINDINGS OF FACT

Procedural History of the Bankruptcy Proceedings

A. On December 7, 2020 (the “Petition Date”), the Debtor filed a

voluntary petition (the “Petition”) for relief under subchapter V of chapter 11 of

the Bankruptcy Code in the United States Bankruptcy Court for the Southern

District of Florida. (ECF #1.)

B. Laura Perryman, the Debtor’s majority shareholder executed the

Petition, Schedules, and Statement of Financial Affairs on behalf of the Debtor

as the Debtor’s Manager. (ECF #1 at 4, 6.) Laura Perryman managed and

controlled the Debtor from the Petition Date through at least March 6, 2021.

(Trustee Dec. ¶11.)

C. On February 19, 2021, the Court entered an Order to Show Cause

Why Debtor Should Not Be Removed as Debtor-In-Possession and Setting Hearing

(“Order to Show Cause”). (ECF #180.) The Order to Show Cause noted that there

were “disputes as to who is in charge of the Debtor, concerns regarding alleged

2 To the extent any of the following findings of fact constitute conclusions of law, they are adopted

as such. To the extent any of the following conclusions of law constitute findings of fact, they are

adopted as such.

interference by the co-founder/majority shareholder, and concerns about the

majority shareholder taking action ultra vires.”

D. On March 8, 2021, following a hearing, the Court entered an Order

Removing the Debtor-in-Possession and Expanding the Powers of Subchapter V

Trustee. (ECF #206.)

E. Subsequently, the Trustee took over operating the business of the

Debtor and possession of all property of the Debtor’s estate. (Trustee Dec. ¶15.)

F. The 9019 Motion and Order Setting Evidentiary Hearing (ECF #235)

were served on all creditors of the Debtor’s estate, all counter-parties to

executory contracts with the Debtor, all current and former directors of the

Debtor, all current and former Managers of the Debtor, all of the Debtor’s

employees, all holders of equity in Stimwave and the Debtor, and any interested

party eligible for notice pursuant to the Court’s CM/ECF system. (ECF ##238,

239.)

The Trustee’s Assessment of the Debtor’s Business and the Settlement

Agreement

G. Upon his appointment, the Trustee examined the Debtor’s business

records. (Trustee Dec. ¶20.) The Debtor’s accounting records reflect that during

the approximately one-year prepetition period the Debtor operated at a net loss

on a cash basis of $591,110. (Trustee Dec. ¶54.) The Trustee concluded that,

absent the Court’s approval of the Settlement Agreement, the Debtor will likely

become administratively insolvent and this chapter 11 case could be converted

to a chapter 7 liquidation. (Trustee Dec. ¶¶48, 50, 55.) If the Settlement

Agreement is not approved, the Debtor’s continued operations would generate a

negative cash flow and the Trustee concluded that ceasing Debtor’s operations

is in the best interests of creditors. (Trustee Dec. ¶¶55-56.)

H. The Trustee acknowledged the existence of a Micron Devices LLC

Manufacturing Agreement with MMC (the “Manufacturing Agreement”) (MMC Ex.

6.) dated January 1, 2020. The Manufacturing Agreement was not listed as an

executory contract on the Debtor’s schedules. (ECF #1 at 30.) The Trustee

testified that he was concerned about the validity of the Manufacturing

Agreement and that he did not thoroughly review the agreement, but his

understanding was that the agreement was supposed to provide inventory to

MMC. (Tr. of April 30,2021 Hearing at 97 (ECF #381.)) The Trustee also

acknowledged the existence of a Master Services Agreement between the Debtor

and MMC (the “Services Agreement”) (MMC Ex. 2.) dated January 1, 2020. The

Services Agreement was listed as an executory contract on the Debtor’s

schedules. (ECF #1 at 30.)

I. Neither the Manufacturing Agreement nor the Services Agreement

has been rejected or assumed by the Trustee, although MMC filed an Expedited

Motion to Compel Assumption of the Manufacturing Agreement and the Services

Agreement (ECF #389) (the “Emergency Assumption Motion”) on May 18, 2019.

The Court has not ruled on the Emergency Assumption Motion. However, the

relief sought will be moot in light of this ruling.

J. The Trustee testified that the proposed payment by Stimwave of

$1,000,000 (the “Settlement Payment”), coupled with the consensual

subordination of all KLIM and Stimwave claims provided for in the Settlement

Agreement, would be sufficient to fund payment in full of administrative and

priority claims and to make a meaningful distribution to allowed unsecured

creditors. (Trustee Dec. ¶49.) Based on his reasoned business judgment, the

Trustee has made a determination that the Settlement Agreement provides a

certain and prompt recovery for creditors and he recommends its approval.

(Trustee Dec. ¶61.)

Alternatives to Settlement

K. The Debtor filed its Subchapter V plan on March 4, 2021 (ECF #196)

(the “Plan”). At a status conference held prior to the hearing on the 9019 Motion,

the Debtor advised the Court that it was not proceeding to confirmation of the

Plan until after the Court ruled on the 9019 Motion.

L. On April 28, 2021 the Debtor filed its Motion, Pursuant to Sections

105(a), 349(b) and 1112(b) of the Bankruptcy Code, for Entry of an Order (a)

Approving Procedures for the Distribution of Assets to Administrative and

Undisputed General Unsecured Creditors; (b) Voluntary Dismissal of the Debtors

[sic] Chapter 11 Case and (c) Granting Related Relief (ECF #311) (the “First Motion

to Dismiss”). The Court denied that motion by Order dated May 4, 2021. (ECF

#343.)

M. On May 6, 2021, the Debtor filed its Motion, Pursuant to Sections

105(a), 349(b) and 1112(b) of the Bankruptcy Code, for Entry of an Order (a)

Approving Procedures for the Distribution of Assets to Administrative and

Undisputed General Unsecured Creditors; (b) Voluntary Dismissal of the Debtors

[sic] Chapter 11 Case and (c) Granting Related Relief (ECF #368) (the “Second

Motion to Dismiss” and together with the First Motion to Dismiss the “Motions

to Dismiss”). In the Second Motion to Dismiss the Debtor stated as one of the

“causes” for dismissal that “the Debtor cannot confirm or consummate a Chapter

11 plan.” The Court denied the Second Motion to Dismiss by Order dated May

14, 2021. (ECF #384.)

N. On April 21, 2021, an entity called MidAtlantic Medical Association,

Inc. (“MidAtlantic”) submitted a letter to the Trustee that expressed an interest

in negotiating with the Trustee for the purchase of Debtor’s assets and liabilities

for $1,750,000 (the “MidAtlantic Letter”). The MidAtlantic Letter was admitted

into evidence as Debtor’s Exhibit 1. The $1,750,000 has been deposited in the

trust account of attorney Adam Skolnick, who represents MMC as well as

MidAtlantic in this case.

O. Another entity called “Cobalt Capital, LLC” made a written offer to

the Trustee that expressed an interest in purchasing the Debtor’s assets free and

clear of all liabilities for $2,000,000. (Tr. of April 30,2021 Hearing at 95:18-22

(ECF #381.)) That offer was not filed with the Court or submitted as evidence at

the Evidentiary Hearing by the Debtor or MMC.

P. The Trustee testified that he had phone conversations with several

other parties about a possible purchase of the Debtor’s assets. Laura Perryman

arranged for several of the calls and attended some but not all of the calls.

However, the Trustee testified, none of those calls resulted in any written offers

being submitted.3

3 Debtor’s counsel claims she knew nothing about either the MidAtlantic Letter or the Cobalt

offer because the Trustee did not tell her about either. It is for this reason that the Court gave

the Debtor the opportunity to file additional exhibits and witnesses with respect to the “best

interests” portion of the Justice Oaks test to be considered at the second day of the Evidentiary

Hearing. However, the Court finds it was reasonable for the Trustee to assume Debtor’s counsel

The Transfer Agreements

Q. The Debtor and Stimwave Technologies Inc. (“Stimwave”) are former

affiliates. (Trustee Ex. 41, 301:24-25.) Laura Perryman formerly served as the

Manager of the Debtor. (Trustee Ex. 24 at 19.) Ms. Perryman also served as

Chief Executive Officer of Stimwave and separated from Stimwave in November

2019. (Goldberg Dec. ¶27; Kho Dec. ¶26.)

R. Between March 2018 and January 2019, the Debtor entered into a

series of agreements with Stimwave pursuant to which the Debtor transferred or

assigned shares it owned in a related entity and certain intellectual property,

including but not limited to licenses, patents, and certain other contractual

rights (the “Assigned IP”), to Stimwave (the “Transfer Agreements”), as follows:

i. Contribution Agreement: The Debtor contributed its ownership

interests (the “StimQ Equity”) in StimQ Medical LLC (“StimQ”) to

Stimwave via the Stimwave Technologies Incorporated Contribution

Agreement dated as of March 25, 2018 (the “Contribution Agreement”).

(Trustee Ex. 3.) Laura Perryman executed the Contribution Agreement

on behalf of both the Debtor and Stimwave. (Trustee Ex. 3.)

ii. License Assignment Agreement. The Debtor assigned all its duties,

liabilities and obligations under certain licenses to Stimwave pursuant

to the Assignment and Assumption Agreement dated as of October 13,

2018 (the “License Assignment Agreement”). (Trustee Ex. 4.) Mark

Coleman, a director, executed the License Assignment Agreement on

behalf of the Debtor, and Ms. Perryman executed it on behalf of

Stimwave. (Trustee Ex. 4.)

knew about the offers due to counsel’s day to day contact with Laura Perryman and the fact that

Debtor’s counsel was working with counsel for MidAtlantic, who also represents MMC, on a daily

basis in connection with the 9019 Motion and other matters. As for Debtor’s counsel’s argument

that had she known about the MidAtlantic Letter sooner she could have negotiated a better deal,

the Court notes that Dr. Gupta, MidAtlantic’s principal, has been involved with this case from

the beginning, and may or may not have been a director of the Debtor when the case was filed

(another of Ms. Perryman’s possibly ultra vires acts), and both counsel and Ms. Perryman had

every opportunity to negotiate any deal with Dr. Gupta well before the MidAtlantic Letter was

sent to Trustee’s counsel.

iii. Patent Assignment Agreement. The Debtor assigned certain patents

and inventions to Stimwave pursuant to the Patent Assignment, dated

as of November 6, 2018 (the “Patent Assignment Agreement”). (Trustee

Ex. 5.) Laura Perryman executed the Patent Assignment on behalf of

both the Debtor and Stimwave. (Trustee Ex. 5.)

iv. Epimed Assignment Agreement. The Debtor assigned to Stimwave all

of its rights under a contract with Epimed International, Inc. (the

“Epimed Contract”) pursuant to the Epimed Assignment Agreement

dated as of January 23, 2019 (the “Epimed Assignment Agreement,”

and together with the License Assignment Agreement and Patent

Assignment Agreement, the “IP Assignment Agreements”). (Trustee Ex.

6.) Mark Coleman, a director, executed the Epimed Assignment

Agreement on behalf of the Debtor, and Ms. Perryman executed it on

behalf of Stimwave. (Trustee Ex. 6 at 4.)

S. At Stimwave’s board meeting on February 22, 2018, Laura Perryman

proposed that she and Debtor could contribute their respective ownership

interests in StimQ Medical LLC to Stimwave for no consideration “on the premise

that she and the holders of Micron Devices already have equity [sic] interests in

the Company [Stimwave] and such contribution was expected not to have an

impact for tax purposes.” (Trustee Ex. 15 at 1.) The Stimwave board authorized

going forward with the contribution. (Trustee Ex. 15) (the “Contribution Board

Resolution”). Three of the members of the Stimwave board were also members

of the Debtor’s board. (Trustee Ex. 15.) There is nothing in the record to indicate

whether the Debtor’s Board of Directors approved the Contribution Agreement.

However, the Contribution Agreement recites that the contribution is for no

consideration, and “qualifies under the appropriate provision of the Internal

Revenue Code of 1986, as amended (the “Code”), as a tax free capital

contribution.”

T. The Debtor’s Board of Directors authorized the IP Assignment

Agreements pursuant to an Action by Written Consent executed on October 13,

2018 (Trustee Ex. 7.) (the “IP Board Consent”).

U. No one has disputed the validity of the Transfer Agreements. On May

3, 2021, Laura Perryman, in her Objection to Stimwave Motion in Limine to

Preclude Testimony (ECF #337), wrote that she had previously testified under

oath as to the validity of her signature on the Transfer Agreements and that

“[t]hese documents were attested to as accurate in the Delaware Chancery Court

proceeding trial.” The basis for contesting the validity of the transfers is the lack

of approval by the members of the Debtor or lack of prior consent of the Debtor’s

board of directors allegedly in violation of The Limited Liability Company

Agreement for Micron Devices LLC (the “LLC Agreement”) (Trustee Ex. 24). See

The Declaratory Judgement Action (defined infra).

V. The LLC Agreement requires an affirmative vote or written consent

of a majority of the outstanding interests (greater than 50%) with respect to any

“action that would constitute a Liquidation Event.” (the “Member Approval

Requirement”) (LLC Agreement, 5.4(b).) A Liquidation Event is defined as “(a) a

liquidation, dissolution or winding up of the Company; (b) a sale of all or

substantially all of the assets of the Company; or (c) a merger or consolidation of

the Company into another entity in which the Members of the Company retain

less than a majority of the voting control of the surviving entity.” (LLC Agreement,

1.26.)

W. Section 5.4(a) of the LLC Agreement states that, without the prior

consent of the Board of Directors, the Manager shall not “enter into any corporate

strategic relationship involving the payment, contribution, or assignment by the

Company or to the Company of money or assets greater than $50,000.”(the

“Board Approval Requirement”).

X. At the time of and following the execution of the Transfer

Agreements, there was significant overlap between the ownership of the Debtor

and Stimwave. (Trustee Exs. 8, 9, 13, 14, 16, 17, and 18; Goldberg Dec. ¶19.)

Y. Following the execution of the Transfer Agreements, Laura

Perryman filed a cancellation of the Debtor’s active status with the Delaware

Secretary of State on December 28, 2018 (the “Certificate of Cancellation”).

(Trustee Ex. 10.) The Debtor closed its only bank account in July 2019. The

Debtor also filed its 2018 federal income tax return indicating that the 2018

return was a final return, and sent each of its members final K-1s indicating the

2018 federal income tax return was the final return for the Debtor. There is

nothing in the Debtor’s records to indicate that any shareholder raised any

concerns or objections after receiving the final K-1. (Trustee Dec. ¶38(d); Trustee

Exs. 8, 13; ECF #1 at 39.)4

The Kennedy Lewis Loan

Z. On May 13, 2019, Stimwave entered into a loan and security

agreement (the “LSA”) with Kennedy Lewis Investment Management LLC (“KLIM”)

under which KLIM received a first-priority lien on and a security interest in

Stimwave’s personal property, including the StimQ Equity and the Assigned IP.

4 The Debtor prepared, and may or may not have filed, a new 2018 tax return sometime in early

2020. (Trustee Ex. 14; Trustee Ex. 41 at 27-28.)

In the course of negotiations, and in the LSA and documents and agreements

executed in conjunction therewith, Laura Perryman, on behalf of Stimwave,

made numerous representations as to Stimwave’s ownership of the Assigned IP

and StimQ Equity. (Trustee Ex. 20 at 3; Ex. A; 4.1, 5.2; Trustee Exs. 21, 22;

Kho Dec. ¶¶19, 20.) Laura Perryman executed the KLIM loan documents on

behalf of Stimwave in her then-capacity as CEO. (Trustee Ex. 20, 21, 22; Kho

Dec. ¶¶19, 20, 21.)

AA. KLIM negotiated and executed the LSA at arm’s length and in good

faith. (Kho Dec. ¶23; Goldberg Dec. ¶26.) KLIM entered into the LSA in reliance

upon Laura Perryman’s representations regarding the Assigned IP and StimQ

Equity, among other things, and the documentation she provided. (Kho Dec.

¶23, Trustee Ex. 29, 30.) At the time the LSA was executed and the perfection

of all liens granted pursuant to the LSA, KLIM had no knowledge that any legal

or factual basis existed, or was claimed to exist, to avoid the Debtor’s transfers

of the StimQ Equity or Assigned IP to Stimwave. (Kho Dec. ¶25.)

Laura Perryman Separates from Stimwave and Seeks to Revive Debtor

BB. In the fall of 2019, Laura Perryman was placed on administrative

leave by the Stimwave board. Ms. Perryman resigned as Stimwave’s CEO on

November 25, 2019, hours before a meeting at which her continued employment

was going to be discussed. (Goldberg Dec. ¶27.)

CC. Subsequent to Ms. Perryman’s resignation, on November 25, 2021,

she filed a Certificate of Correction of the Certificate of Cancellation in which

Ms. Perryman stated, “Due to clerical error, the entity was voluntarily cancelled

when it should not have been.” (Trustee Ex. 23.)

The Adversary Proceedings and Stimwave’s and KLIM’s Claims

DD. Beginning in December 2019, Stimwave sued the Debtor and Laura

Perryman in connection with, among other things, confirming the effectiveness

of the Transfer Agreements, the ownership and use of the Assigned IP and the

StimQ Equity, and the inclusion of those assets as KLIM’s loan collateral (the

“Prepetition Litigation”).5 See Stimwave Tech., Inc. v. Micron Devices, LLC, No.

2019-1003-SG (Del. Ch. 2019) (the “Delaware Action”). The Debtor and Laura

Perryman filed counterclaims and third-party claims in the Delaware Action,

including third-party claims against KLIM. (Goldberg Dec. ¶30.) The Delaware

Action was set for trial in January 2021.6 (Goldberg Dec. ¶30.)

EE. The Debtor commenced two adversary proceedings against

Stimwave (the “Adversary Proceedings” and collectively with the Prepetition

Litigation, the “Litigation Matters”). In Case Number 21-01033-LMI (the

“Turnover Action”), the Debtor seeks, inter alia, turnover of funds that it claims

Stimwave owes the Debtor, totaling $4,479,928.27 (consisting of $1,081,405.16

owed by Stimwave and the remainder owed by Stimwave’s affiliates). In Case

Number 21-01034-LMI (the “Declaratory Judgment Action”), the Debtor seeks,

inter alia, a declaratory judgment that the Contribution Agreement, License

Assignment Agreement, and the Patent Assignment Agreement were null and

5 For a detailed summary of the Prepetition Litigation, see allegations in ECF ##27 and 45.

6 Following the Debtor’s petition for bankruptcy protection, the Delaware Action was removed to

the United States District Court for the District of Delaware.

void ab initio, and for related monetary relief.7 KLIM intervened in the

Declaratory Judgment Action. (Declaratory Judgment Action, ECF ##8, 19.) On

April 26, 2021, Stimwave and KLIM filed answers, affirmative defenses, and

counterclaims in the Declaratory Judgment Action. (Declaratory Judgment

Action, ECF ##40, 42.)

FF. Stimwave has asserted general unsecured claims against the

Debtor’s estate in the amounts of $67,929.07, $3,772,073.00, and

$3,042,158.28. See Claim Nos. 18-1, 19-2, 20-2. (Trustee Exs. 43, 44, 35.)

Stimwave also has an allowed administrative claim against the Debtor’s estate

in an amount to be determined by the Court. (ECF #163; Trustee Ex. 48 ¶¶5-

7; ECF #157 ¶3.)

GG. KLIM has asserted general unsecured claims against the Debtor

based on fraudulent inducement, see Claim No. 23-1, as well as contingent

secured claims against the Debtor that exceed $20,000,000, see Claim No. 22-

3, KLIM also has an allowed administrative claim against the Debtor’s estate in

an amount to be determined by the Court. (ECF #163; Trustee Ex. 48 at ¶¶5-

7; ECF #174 ¶3.)

HH. The Debtor has filed objections to the Stimwave filed claims and the

KLIM filed claims. (ECF ##329, 330, 358, 360). The basis for the Debtor’s

objection to the Stimwave claims is that the Transferred Assets were conveyed

without the proper authority of Debtor. The basis for the Debtor’s objection to

7 The Declaratory Judgment Action did not seek a declaratory judgment as to the Epimed

Assignment. However, the validity of the Epimed Assignment was a subject of the declaratory

judgment sought by Stimwave, and contested by Debtor, in Delaware Action. (Goldberg Dec.

¶32, n. 6.)

the KLIM claims is, with respect to the unsecured claims based on fraudulent

inducement, that the signatory to the LSA Agreement is Stimwave, not the

Debtor and so any obligation is not an obligation of the Debtor; and with respect

to the contingent secured claim, is that there was no transfer of the assets

claimed as collateral by KLIM and that KLIM’s reliance of any misrepresentations

made by Stimwave or Laura Perryman rests squarely with those parties and not

with the Debtor.

The Trustee’s Conclusions Supporting the Settlement

II. The Trustee has concluded that it is highly uncertain whether the

Debtor could prevail on the merits of the Litigation Matters, including any

Prepetition Litigation forming the basis of the Settled Claims. (Trustee Dec. ¶35.)

JJ. The Trustee has concluded that the ability of the Debtor’s estate to

collect on any monetary judgment from Stimwave in the Turnover Action is

uncertain, given the claimed lien of KLIM on the property subject to the Transfer

Agreements, and the likelihood that the Debtor’s estate would need to satisfy all

of KLIM’s secured claims and all administrative expense claims prior to realizing

any net benefit for creditors of the Debtor’s estate. (Trustee Dec. ¶40.)

KK. The Trustee has concluded that the ability of the Debtor’s estate to

realize a net benefit from the Declaratory Judgment Action will be affected by the

likelihood of claims in favor of KLIM and Stimwave resulting from, among other

barriers described in the declaration, the representations made by Laura

Perryman in the various Transfer Agreements which are directly inconsistent

with the allegations of the Debtor, and Laura Perryman’s assertion of her Fifth

Amendment right against self-incrimination with respect to everything relating

to these claims. (Trustee Dec. ¶¶38(e), 42.)

LL. The Trustee has testified that the Settled Claims, as defined by the

9019 Motion, are deeply complex in nature, involve significant factual disputes

dating as far back as 2013, and require resolution of legal issues spanning

corporate governance, contract, tort and intellectual property law. (Trustee Dec.

¶44.) The Trustee has further concluded that adjudication of the Settled Claims

would require substantial efforts and expense by the parties to complete

discovery, develop their claims and defenses, and prepare for trial. (Trustee Dec.

¶45.)

MM. With the exception of the claims alleged by Stimwave and KLIM

against the Debtor’s estate, there do not exist any recorded encumbrances

against any property of the Debtor’s estate. (Trustee Dec. ¶31; Debtor’s

Schedules (ECF #1); Trustee Exs. 31, 32, 33, 34, 39, 40.)

NN. No party has appeared in this case alleging an encumbrance against

property of the Debtor’s estate. (Trustee Exs. 31, 32, 33, and 34.)

OO. A public records search reflects that there are no liens in the Palm

Beach, Miami Dade or Broward Counties, the state of Florida, the state of

Delaware, or the United States Patent and Trademark Office. (Trustee Exs. 39,

40.)

CONCLUSIONS OF LAW

1. The Bankruptcy Court has jurisdiction over this motion pursuant to

28 U.S.C. §§157 and 1334. This matter is a core proceeding within the meaning

of 28 U.S.C. §157(b)(2).

2. Venue in this Court is proper pursuant to 28 U.S.C. §§1408 and

1409.

3. The statutory and legal predicates for the relief granted herein are

sections 105(a), 363(b), and 365 of the Bankruptcy Code, Bankruptcy Rule

9019(a) and Local Rule 9019-1(A).

4. Pursuant to Fed. R. Bankr. P. 2002, 6004, 6006, and 9019, the

parties to the Settlement Agreement have complied with all notice requirements,

which constitutes good and adequate notice, and no further notice is necessary.

5. The Subchapter V Chapter 11 Trustee has authority to file and

prosecute the 9019 Motion pursuant to Fed. R. Bank P. 9019, 6009 and 28

U.S.C. §§323, 1183(b)(5).

The Settlement Agreement Meets the Standard for Approval

6. A compromise or settlement under Bankruptcy Rule 9019 must be

fair, equitable, reasonable, and in the interests of the debtor’s estate. See

Protective Comm. for Indep. Stockholders of TMT Trailer Ferry, Inc. v. Anderson,

390 U.S. 414, 424 (1968); In re Se. Banking Corp., 314 B.R. 250, 272 (Bankr.

S.D. Fla. 2004). A proposed settlement will be approved unless it “fall[s] below

the lowest point in the range of reasonableness. See, e.g., Martin v. Pahiakos (In

re Martin), 490 F.3d 1272, 1274 (11th Cir. 2007); In re Arrow Air, Inc., 85 B.R.

886, 891 (Bankr. S.D. Fla. 1988). In considering a proposed settlement, the

bankruptcy court “may certainly give weight to the trustee’s informed judgment

that a compromise is fair and equitable.” In re S & I Investments, 421 B.R. 569,

584 (Bankr. S.D. Fla. 2009).

7. A trustee exercises sound business judgment when he evaluates

“the strength and weaknesses of the potential claims and the cost and time it

would take to litigate the claims.” See United States v. Hartog (In re Exporther

Bonded Corp.), 597 B.R. 673, 679 (S.D. Fla. 2019), appeal dismissed sub nom.

In re Exp. Bonded Corp., No. 19-11937-FF, 2019 WL 4137769 (11th Cir. July 15,

2019).

8. In measuring whether the Trustee’s business judgment has been

appropriately exercised, the Court must consider the following factors: (i) the

probability of success in litigation; (ii) the difficulties, if any, to be encountered

in the matter of collection; (iii) the complexity of the litigation involved and the

expense, inconvenience, and delay attending it; and (iv) the paramount interest

of the creditors and a proper deference to their reasonable views in the premises.

Wallace v. Justice Oaks II, Ltd. (In re Justice Oaks, II, Ltd.), 898 F.2d 1544, 1549

(11th Cir. 1990).

9. “[P]ublic policy strongly favors pretrial settlement in all types of

litigation because such cases, depending on their complexity, [like the Adversary

Proceedings] ‘can occupy a court’s docket for years on end, depleting the

resources of parties and the taxpayers while rendering meaningful relief

increasingly elusive.’” Shearson Lehman Brothers, Inc. v. Munford, Inc. (In re

Munford, Inc.), 97 F.3d 449, 455 (11th Cir. 1996) (quoting U.S. Oil & Gas v.

Wolfson, 967 F.2d 489, 493 (11th Cir. 1992)).

10. Based on the findings of fact set forth herein, the Court concludes

that the arguments, representations, proffers, and other evidence introduced in

support of the 9019 Motion at the Evidentiary Hearing support and warrant the

conclusions of law that the Settlement Agreement is an appropriate exercise of

the Trustee’s business judgment, as it falls well above the lowest point in the

range of reasonableness, and also meets the standards set out in In re Justice

Oaks II, Ltd., 898 F.2d at 1549.

11. Probability of Success. The Court finds that the probability of

success on the litigation in the Turnover Action and the Declaratory Judgment

Action is highly uncertain at best, based on the Court’s review of the evidence

and applicable Delaware law. The Court finds the Trustee’s reasoning is a sound

analysis of the challenges to success. The Court cannot ignore that the key

witness for the Debtor in all the Litigation Matters, and any objection to claims,

is Laura Perryman. Yet Ms. Perryman has asserted her Fifth Amendment right

against self-incrimination with respect to every element of any claims or defenses

the Debtor might assert. Thus, regardless of any of those claims or defenses are

actually viable, the Debtor would be unable to put on an effective case. See SEC

v. Zimmerman, 854 F. Supp. 896, 899 (N.D. Ga. 1993) (citing McGahee v. Massey,

667 F.2d 1357, 1362 (11th Cir. 1982); In re Edmond, 934 F.2d 1304, 1308 (4th

Cir. 1991)).

12. Difficulties in Collection. This factor is not as compelling with

respect to approval of the Settlement Agreement. The Court finds that the ability

of the Debtor’s estate to collect on any monetary judgment from Stimwave in the

Turnover Action could be problematic, given the claimed lien of KLIM on the

property subject to the Transfer Agreements. Jeff Goldberg testified that, if the

Settlement Agreement is not approved, Stimwave will continue to litigate this

issue because “resolution of the dispute regarding the Transfer Agreements is

critical to Stimwave’s going concern value.” (Goldberg Dec. ¶34.) The Litigation

Matters are certainly expensive8 and have clearly been a financial drain on the

Debtor. Thus, it is fair for the Trustee to assume that collection, even if the

Trustee were able to overcome the evidentiary hurdles, might be at least

problematic.

13. Complexity of the Litigation. The Court finds that the Litigation

Matters are complex in nature by virtue of significant factual disputes

exacerbated by serious discovery violations9, and require resolution of legal

issues spanning corporate governance, contract, tort, and intellectual property

law.

14. Paramount Interest of the Creditors. Several creditors support the

9019 Motion. The Debtor has argued that the Court should not consider the

support for the 9019 Motion by Stimwave or KLIM, both of whom are disputed

creditors by virtue of objections filed by the Debtor and not impartial, or the

support for the settlement by creditor Stryker Corporation, another creditor to

8 Prepetition litigation attorneys’ fees and costs are at least $3,042,158.28 (Claim No. 20-2, page

6).

9 See Final Report and Recommendation of the Special Discovery Master Concerning Motions

Directed to Represented Defs, Stimwave Tech. Inc. v. Laura Tyler Perryman et al., Case No. 2019-

1003-SG (Del. Ch. Nov. 6, 2020), as adopted by Order Adopting Report and Recommendations,

Stimwave Tech. Inc. v. Laura Tyler Perryman et al., Case No. 2019-1003-SG (Del. Ch. Nov. 20,

2020). The Delaware court’s order is attached as Exhibit H to ECF #45.

whose claim the Debtor has filed an objection (ECF #350). However, while there

may be times that a court might disregard or discount the support of disputed

creditors, the Debtor did not cite to any authority, or any persuasive facts that

would support the Court disregarding these creditors in this case.10

15. Moreover, the creditors whose interests this Court must consider

include the administrative creditors, including the landlord, the Subchapter V

Trustee and his professionals. See In re Vazquez, 325 B.R. 30, 41 (Bankr. S.D.

Fla. 2005).

16. Since the Debtor has acknowledged that it cannot proceed with a

confirmable plan, the only other option is dismissal.11 For the reasons previously

cited by the Court at the Evidentiary Hearing, as evidenced by the two orders

denying the two last minute Motions to Dismiss - the “structured dismissals” the

Debtor has asked for, first directly and then indirectly - would not pass muster

under Czyzewski v. Jevic Holding Corp., 137 S. Ct. 973 (2017). Thus, if this case

were dismissed it would have to be a straight dismissal. The Court finds that,

10 Debtor’s counsel has argued that this Court cannot rule on the 9019 Motion without first

adjudicating the Debtor’s objections to the Stimwave and KLIM claims. However, as the Court

explained to Debtor’s counsel at the Evidentiary Hearing, the very nature of compromise

considers that there are unresolved issues that are being compromised. Moreover, the bases of

the Debtor’s objections are the issues that are being resolved in the Settlement Agreement. “In

approving the settlement agreement, the Bankruptcy Court did not have to rest its approval upon

a resolution of the ultimate factual issues underlying the disputes that are compromised.” U.S.

v. Hartog, 597 B.R. at 679. Finally, the Court notes the Debtor waited to file the objections until

April 30, 2021, the same day as the first day of the Evidentiary Hearing.

11 The Debtor had every opportunity both before and after the 9019 Motion was filed to file an

amended plan that included an exit strategy the incorporated MidAtlantic’s offer, subject to

higher and better bids. But, putting aside the confirmability of such a plan, the Debtor never

did so. Moreover, every other exit strategy motion filed by the Debtor, including the two Motions

to Dismiss (ECF ##311, 368) and the motion to sell free and clear of liens (ECF #364), were filed

at the last minute, literally on the eve of the Evidentiary Hearing. Thus, the Court finds that the

Debtor has only filed these motions for the purpose of seeking to delay adjudication of the 9019

Motion and not with the good faith intention to put forth a viable alternative. Indeed, the Court

gave the Debtor a full week to put together a case on the “best interests” element and the Debtor’s

presentation fell well short of demonstrating to this trier of fact that the Trustee’s business

judgment was unreasonable on this point.

even if, after dismissal, MidAtlantic went through with an offer, at a minimum

the administrative claimants would probably not get paid. There is nothing this

Debtor has done that would lead this Court to believe that the Debtor would

honor any financial commitment, and certainly not to the Trustee or his

professionals, regardless of whether the Debtor was legally obligated to do so.

17. The MidAtlantic offer does not offer a viable solution for the Trustee

if the case was not dismissed. The sale had no details other than money in a

trust account. While Dr. Gupta, the principal of MidAtlantic, is clearly a

passionate doctor, with very legitimate reasons for wanting to pursue the success

of the Moventis product12, that is not relevant to the criteria either the Trustee

or the Court must consider. The MidAtlantic offer contemplates a further

negotiating period; it does not specify the additional terms upon which it is

conditioned; it does not contemplate any good faith deposit; it does not specify

what assets of the Debtor MidAtlantic seeks to purchase or the process by which

the sale would take place. Moreover, the MidAtlantic offer proposes to pay certain

creditors while not paying or reserving for all creditors’ claims which is not

authorized by the Bankruptcy Code, does not specify how or by whom the

existing litigation would be funded (although Dr. Gupta testified he would fund

the litigation with his personal money if need be), does not address the issue of

a reserve in the event of an adverse judgment, including the potential attorney

fees liabilities13, or address the effect such adverse judgment would have on

12 The product that MMC has apparently developed using the technology that is the subject of

the Litigation Matters.

13 If the Debtor did not prevail in the pending Prepetition Litigation Stimwave could seek

prevailing party legal fees under federal patent law, see 35 U.S.C. §285, and the Florida Unfair

and Deceptive Trade Practices Act, see Fla. Stat. §501.2105.

parties holding administrative, priority, and general unsecured claims against

Debtor’s estate. These postpetition administrative expenses would likely be

substantial, and such liability would reduce or eliminate any recovery for

creditors of the estate.

18. Dr. Gupta’s testimony that he would “close that very day” is an

uninformed promise. With so many blanks to fill, it is also an empty promise.

Thus, the Debtor has not provided any alternative that would benefit the

creditors.

19. The Court finds that the Settlement Agreement is in the paramount

interest of creditors because absent court approval of the settlement and the

receipt of the settlement payment, the Debtor will likely become administratively

insolvent. This is supported by the Trustee’s projections that continued

operations will generate a negative cash flow and will not be sufficient to cover

administrative expenses. (Trustee Dec. ¶55-56.)14, 15

20. The proposed settlement payment, coupled with the consensual

subordination of all claims of KLIM and Stimwave, projects to fund a meaningful

distribution to holders of undisputed allowed claims, all secured claims,

subchapter V administrative expenses, all unsecured priority claims, with

approximately $100,000 available for distribution to general unsecured

14 Brandyn Perryman testified that the Debtor could make “tens of millions of dollars” but neither

MMC nor the Debtor provided any evidence to support this statement. Mr. Perryman’s testimony

contradicts not only the Trustee’s financial analysis, which is based on the Debtor’s books and

records (Trustee Dec. ¶¶19-20, 48, 54-55) but also the Debtor’s own projections appended to the

Plan.

15 Debtor argues in its Objection and at the Evidentiary Hearing that the Debtor would have

plenty of money if the Trustee would just sell MMC the inventory that it is allegedly entitled to

purchase. However, the Court finds the Trustee’s reasons for not concluding that sale are sound.

creditors, in addition to recoveries from avoidance actions and professional

negligence claims. (Trustee Dec. ¶¶49, 59.)

The Transfer Agreements Are Valid

21. The Court concludes that the Transfer Agreements are valid,

binding, and enforceable as of the respective date of each Transfer Agreement’s

execution.

22. The only issue raised regarding the enforceability of the Transfer

Agreements is that they were all executed without either the Member Approval

Requirement in the Debtor’s LLC Agreement, or, in the case of the Contribution

Agreement, the Board Approval Requirement. However, the Court finds that even

if the Member Approval Requirement or Board Approval Requirement was

triggered by any of the Transfer Agreements, the Debtor may not raise that in

order to seek to avoid the Transfer Agreements. Moreover, even if the Member

Approval Requirement or Board Approval Requirement was appropriately raised,

it does not appear that any of the Transfer Agreements triggered a Liquidation

Event or a corporate strategic relationship as those terms are defined under the

LLC Agreement. And, finally, even if any one of the Transfer Agreements

constituted a Liquidation Event, the members of the Debtor ratified the Transfer

Agreements after the fact.

23. A corporation may not seek to invalidate an act or the transfer of

personal property on the basis that the corporation did not have the authority to

take such act or convey such property. See 8 Del. C. §124. Assuming, arguendo,

that any of the Transfer Agreements were within the Member Approval

Requirement or the Board Approval Requirement the Transfer Agreements were

voidable rather than void.

24. A contract entered into by a Delaware limited liability company

without the receipt of an approval required under its operating agreement will

ordinarily fall within the power and capacity of the company notwithstanding the

failure to obtain such approval. CompoSecure, L.L.C. v. CardUX, LLC, 206 A.3d

807, 817 (Del. 2018). The remedies available to shareholders where a corporation

engages in a transaction for which it lacks capacity or power, are enumerated in

Section 124 of Delaware’s General Corporation Law and do not include the ability

to unwind, reverse, or void a consummated transaction on the basis that it falls

outside the corporation’s power and authority.16 Se. Pennsylvania Transp. Auth.

v. Volgenau, No. CIV.A. 6354-VCN, 2012 WL 4038509, at *3 (Del. Ch. Aug. 31,

2012), aff'd, 91 A.3d 562 (Del. 2014) (Under Delaware Law, “corporate actions

will not be set aside and that capacity can only be challenged in three instances

[identified in 8 Del. C. §124]”). Because neither of the Adversary Proceedings17

falls into one of these three procedural categories, the Transfer Agreements are

enforceable irrespective of whether Member or Board approval was required

16 8 Del. C. §124 titled Effect of lack of corporate capacity or power; ultra vires provides: “No act

of a corporation and no conveyance or transfer of real or personal property to or by a corporation

shall be invalid by reason of the fact that the corporation was without capacity or power to do

such act or to make or receive such conveyance or transfer, but such lack of capacity or power

may be asserted: (1) In a proceeding by a stockholder against the corporation to enjoin the doing

of any act or acts or the transfer of real or personal property by or to the corporation. . . . (2) In

a proceeding by the corporation . . . against an incumbent or former officer or director of the

corporation, for loss or damage due to such incumbent or former officer’s or director’s

unauthorized act; (3) In a proceeding by the Attorney General to dissolve the corporation, or to

enjoin the corporation from the transaction of unauthorized business.”

17 Since the beginning of this bankruptcy case all parties to the Prepetition Litigation, including

Stimwave and KLIM ,have expressed a willingness to have all the Debtor-related litigation relating

to the issue of ownership of the property subject of the Transfer Agreements, litigated in the

Adversary Proceedings.

25. Even if the Debtor was not barred procedurally from asserting lack

of authority as a basis to set aside the Transfer Agreements, it does not appear

that any of the Transfer Agreements constituted a Liquidation Event requiring

Member approval. None of the Transfer Agreements constitutes a merger or

consolidation. No merger or consolidation agreements were prepared or

contemplated. Moreover, even if there were some basis to treat the Transfer

Agreements as deemed mergers or consolidations, the members of Stimwave and

of the Debtor at the time of the transfers were either all the same or virtually the

same, such that the majority of voting control survived.

26. The Transfer Agreements did not constitute a liquidation,

dissolution or winding up of the Debtor. The only acts that constituted a

liquidation, dissolution or winding up of the Debtor were the filing by Laura

Perryman of the Certificate of Cancellation and the filing of the 2018 final tax

return. Those acts were clearly ratified by the members of the Debtor since none

of them objected to, or even commented on, the wind down when they received

the final K-1s.

27. None of the Transfer Agreements constituted a sale of all or

substantially all of the assets of the Debtor. While it is clear that with the last

Transfer Agreement there were no remaining assets in the Debtor, the LLC

Agreement does not say “sale or transfer”; it just says “sale”. And even this

provision would have no applicability to the Contribution Agreement which was

clearly not a transfer of either all or substantially all of the Debtor’s assets, that

agreement was signed months before the other Transfer Agreements were signed.

28. The Contribution Agreement might constitute a “corporate strategic

relationship” under the LLC Agreement, but, even if the Debtor were

procedurally able to challenge the possible lack of board authority, the fact that

three members of the Debtor’s Board of Directors signed the Contribution Board

Resolution would create a significant hurdle to any such challenge.

29. The License Assignment Agreement and the Patent Assignment

Agreement were both executed in accordance with the IP Board Consent. The IP

Board Consent makes clear that the execution of these agreements was not a

sale, but rather, as set forth in the IP Board Consent, a transfer between two

entities with the same ownership that “would improve the value and business

prospects for Stimwave and better enable each of the respective companies to

operate more efficiently.” Not only was this not a contemplated sale, it was also

not contemplated that the Debtor would cease existence after the agreements

were executed. Indeed, after the License Assignment Agreement and the Patent

Assignment Agreement were executed, the Debtor clearly had assets left; those

were conveyed through the final Transfer Agreement, the Epimed Transfer

Agreement, which agreement the Debtor has not sought to set aside in the

Declaratory Judgment Action.

30. The Court finds that even if the Debtor could assert lack of member

or board approval, which it cannot, and even if board approval or member

approval was required, which it was not, the Court finds that at least a majority

of the members of the Debtor were aware or became aware of the transfers. First

of all, all the members received final K-1s sometime in early 2019. That is a

clear indication that the Debtor had transferred its assets. Second, the directors

who signed the IP Board Consent (Laura Perryman, Robert Anderson, and Mark

Coleman) held 37.32% of the interests in the Debtor. Mr. Goldberg testified18

that the following unit holders were also aware of the transfers: (i) Echo

Vibration Limited a/k/a Orchid, which held 6.15% of Debtor’s units and whose

designee on the Stimwave board was present as an observer at the Stimwave

board meeting at which the IP Assignments were approved (Goldberg Dec. ¶17;

Trustee Exs. 8, 25); (ii) Elizabeth Greene, who owned 0.33% of the Debtor’s units

and acted as Secretary at the same Stimwave board meeting (Goldberg Dec. ¶17,

Trustee Ex. 8); (iii) the Debtor’s current Manager Patrick Larson, who was an

employee of Stimwave and owned 5.84% of the Debtor’s units (Goldberg Dec.

¶ 17; Trustee Exs. 11, 8); and Mark Loev, a current member of Stimwave’s board

of directors who owned 0.85% of Debtor’s units (Goldberg Dec. ¶17; Trustee Ex.

8). Those interests, together with the interests of Ms. Perryman and Messrs.

Coleman and Anderson, constitute a majority of Debtor’s units as of December

31, 2018, a total of 50.49%.19 None of these investors sought to repudiate or

challenge the transfers. Based on this, Stimwave might be able to seek

application of equitable doctrines such as acquiescence, ratification, and laches

to the Debtor’s challenges to the transfers.20

18 No one disputed Mr. Goldberg’s testimony on this point or provided contradictory evidence.

19 Stimwave also owned over 5% of Debtor at the time, bringing the total units held by members

with knowledge of the Transfer Agreements to over 55%, well over the majority required by the

LLC Agreement.

20 The equitable doctrine of acquiescence could apply on the basis that the Debtor’s members

with knowledge of their rights and the material facts, (1) remained inactive for a considerable

time; or (2) freely did what amounts to recognition of the Transfer Agreements; or (3) acted in a

manner inconsistent with the subsequent repudiation, which leads the other party to believe the

act has been approved. Klaassen v. Allegro Development Corp., 106 A.3d 1035, 1047 (Del. 2014).

The doctrine of ratification would apply on the basis that the conduct of the Debtor’s members

was “such as reasonably to warrant the conclusion that [they] accepted or adopted” the Transfer

Agreements. Genger v. TR Invs., LLC, 26 A.3d 180, 195 (Del. 2011). Laches would apply on the

basis that the Debtor’s members had (i) actual or constructive knowledge of the Transfer

The Debtor’s Assets Will be Transferred Free and Clear of Liens, Claims and

Encumbrances

31. The property the Trustee is required to convey under the Settlement

Agreement is free and clear of all claims, liens, and encumbrances as authorized

pursuant to 11 U.S.C. §363(f)(2). No lien was of record in any relevant

jurisdiction and no party alleging an encumbrance against property of the

Debtor’s estate has interposed an objection to the proposed conveyance under

the Settlement Agreement.

Agreements; (ii) unreasonably delayed in bringing any claim; and (iii) prejudiced Stimwave as a

result. Homestore, Inc. v. Tafeen, 888 A.2d 204, 210 (Del. 2005). And of course, the doctrine of

unclean hands would apply to any challenge by Laura Perryman, the architect of all of the

Transfer Agreements. The doctrine of unclean hands would apply to any individuals who

authorized, and are now seeking to repudiate, or who made and benefitted from later statements

concerning the validity of, the Transfer Agreements. Encite LLC v. Soni, No. 2476–VCG, 2011 WL

5920896, at *23 (Del. Ch. Nov. 28, 2011) (unclean hands applies where conduct would would

“offend the very sense of equity”).

The Debtor’s Objection Presents Further Delay with No Evidence of a Viable

Alternative Settlement or Plan

32. The Debtor’s amended objection to the 9019 Motion (ECF #317) (the

“Debtor’s Objection”) requests further time to “allow for a restructuring plan

which will not require liquidation” and additional “time to consider the offer

presented” by the Debtor’s First Motion to Dismiss. (ECF #317, ¶¶2-3, 5, 7.) The

Court has already addressed both the untimeliness of these arguments and the

reasons why they are not sufficient to overcome the Trustee’s evidence.

MMC’s Objection is Overruled

33. MMC filed an objection to the 9019 motion (“MMC’s Objection”) on

April 28, 2021 (ECF #312). MMC’s Objection is based on the contention that the

proposed Settlement Agreement would “force it to forfeit its property” (ECF #312,

at 2), and “will cause MMC to fail as well” (ECF #312, ¶6). The premise of this

objection is that because MMC has created a product using the technology that

is the subject of the Litigation Matters, an agreement that resolves the ownership

of the underlying technology will interfere with MMC’s product and will allow

Stimwave to compete directly with MMC and use MMC’s know-how.

34. MMC did not introduce any evidence that the Debtor is in possession

of MMC’s property. Section 2.1 of the Settlement Agreement states that Debtor

is conveying only “Debtor’s right, title and interest in, to, and under the

Transferred Assets” and the Trustee has submitted unrebutted testimony that

the Settlement Agreement does not convey MMC’s property. (Trustee Dec. ¶57;

Trustee Ex. 2 at 9.) MMC has argued, including in the Emergency Assumption

Motion, that Debtor is holding inventory, which the Trustee refuses to sell to

MMC, with a total value of $250,000, which inventory can only be used by MMC.

But MMC did not file the Emergency Assumption Motion until one week after

competing orders were submitted to the Court, almost two weeks after the

second day of the Evidentiary Hearing, almost three weeks after MMC’s counsel

made an ore tenus motion seeking the sale and almost six weeks after the 9019

Motion was filed.21 Moreover, the sale of the inventory to MMC would interfere

with the Trustee’s obligations under the Settlement Agreement, if the 9019

Motion were to be granted. And, the Trustee testified he was concerned that the

Manufacturing Agreement was fabricated due to its sudden appearance. The

inventory is property of the Debtor, not property of MMC, and the Trustee has

the right to sell it.

35. The evidence shows that MMC can negotiate directly with the third

parties that the Debtor was working with to supply MMC. Moreover, there was

no evidence presented by MMC that there are any unique FDA approvals that

the Debtor has that requires the Debtor’s continued operations for the benefit of

MMC.22

36. A consequence of approval of the 9019 Motion apparently will expose

MMC to litigation regarding patent infringement. That is not the Court’s concern.

21 This delay does not excuse the Trustee’s delay in failing to file a motion to reject the

Manufacturing Agreement and the Services Agreement.

22 At the conclusion of the first day of the Evidentiary Hearing counsel made an ore tenus motion

to compel the Trustee to sell the inventory under the terms of the Manufacturing Agreement

because “there are patients, pursuant to the FDA studies, that require and need these devices.”

(Tr. of April 30,2021 Hearing at 231 (ECF #381.)) The Court directed the parties to determine if

anyone was in danger, and if so, to file an emergency motion. No emergency motion was filed,

and, until May 18, 2021, MMC did not file any motion seeking to compel the sale.

The Court notes that Laura Perryman is in control of MMC.23 Ms. Perryman

knows better than anyone that any intellectual property that she used to develop

MMC’s devices, which intellectual property she had previously caused to be

transferred to Stimwave, carried a risk.24

The Other Objections Are Overruled

37. The objections filed by individuals who identify themselves as former

employees and priority wage creditors – Maryam Amiri (ECF #269), Brandyn J.

Perryman (ECF #270), Patrick Larson (ECF #271), Marlene Pena (ECF #272),

Ronald Perryman (ECF #273), and Luis Fernandez (ECF #290) – are overruled

because these objections do not contest any of the Justice Oaks factors; rather

they raise an issue as to projected employment with an affiliate of the Debtor,

which is wholly unrelated to the legal standard for approving a settlement.

Finally, the Trustee has submitted unrebutted testimony that if the Settlement

Agreement is approved, he anticipates these creditors’ unsecured priority claims

will be paid in full. Thus, these objections are overruled.

38. Gary Perryman filed an objection to the 9019 Motion based on his

belief that the Debtor and MMC “will enable payment in full according to the

restructure plan.” (ECF #274.) Gary Perryman did not submit any evidence to

support his objection, nor did he participate in the Evidentiary Hearing.

23 The fact that Ms. Perryman may or may not be an interest holder doesn’t seem to have any

impact on her total control of MMC. She created MMC. (MMC Ex. 22.)

24 Whether or not MMC’s product is “better” than what Stimwave has or has not developed is not

relevant to this Court’s decision.

Moreover, the Debtor has not advanced its Plan and has now acknowledged it

cannot reorganize. Thus, this objection is overruled.

39. Cobalt Capital, LLC filed an objection to the 9019 Motion. (ECF

#322.) As stated on the record at the Evidentiary Hearing on April 30, 2020,

Cobalt Capital, LLC is not a creditor of the estate, and has no standing to object

to the 9019 Motion. (Tr. of April 30, 2021 Hearing at 53:23-54:2 (ECF #381.))

40. After the conclusion of the Evidentiary Hearing, Laura Perryman

filed an untimely objection to the 9019 Motion. (ECF #383.) Much of the

objection sets forth arguments that were raised by others and are addressed in

this Order. Some of the objections lay out facts that were never introduced into

evidence. Ms. Perryman had the opportunity to present evidence at the

Evidentiary Hearing but chose not to do so. Thus, this objection is overruled as

well.

BASED UPON THE FINDINGS OF FACT AND CONCLUSIONS OF LAW,

IT IS HEREBY ORDERED as follows:

1. The Objections are OVERRULED and the 9019 Motion is GRANTED.

2. The Settlement Agreement25, as modified in ¶¶9 and 14 below, is

APPROVED.

3. Pursuant to 11 U.S.C. §363, upon entry of this Order and

compliance with the requirements to close set forth under the Settlement

Agreement, all of Debtor’s right, title, and interest in, to, and under the

Transferred Assets shall be transferred by the Trustee to the Stimwave Parent

25 All capitalized terms not defined in this Order shall have the meaning ascribed in the

Settlement Agreement as corrected (Trustee Ex. 56). To the extent the defined meanings differ,

the definitions in the Settlement Agreement shall control.

(or its designee), or pursuant to Section 2.1(d) of the Settlement Agreement, a

KLIM Party or its Affiliate, as the case may be free and clear of all encumbrances.

The Transferred Assets consist of all of Debtor’s assets and properties of every

type and description, including but not limited to tangible, intangible,

intellectual, personal, and real, and Causes of Action (whether known or

unknown and whether or not currently asserted, and whether based on tort,

contract, statute, common, law of other authority or theory), including: (i) the

Transferred Contracts; (ii) all technical information owned or co-owned by the

Debtor, including all technical information, know how, masks, software, and

other information or data related in any way to any medical device of any type;

(iii) all communications with legal counsel providing advice in any way related to

patents or patent applications in any form whatsoever, including paper, digital,

electronic, however or wherever stored; and (iv) the assets described in Schedule

1.1 to the Settlement Agreement, and in each case, all of Debtor’s rights with

respect thereto, but excluding the Retained Assets and the Micron Assignment

Documents.

4. The transfer of the Transferred Assets will be in all respects a valid,

legal, and effective transfer of property under Section 363 of the Bankruptcy

Code. The transfer is being made at arm’s length and Stimwave and KLIM are

good faith purchasers entitled to the protections of 11 U.S.C. §363(m).

5. At any time prior to the expiration of the Designation Right Deadline,

the Stimwave Parties may designate any of the Debtor’s executory contracts or

unexpired leases to be assigned to the Stimwave Parties by the Trustee pursuant

to 11 U.S.C. §365. To exercise the designation rights provided in Section 2.1(e),

the Stimwave Parties shall file and serve a Designation Document on the Trustee

and any counter-party to the executory contract(s) or unexpired lease(s) subject

to the Designation Document. The Stimwave Parties shall assume all liabilities

associated with a Designated Agreement assigned to the Stimwave Parties upon

the exercise of any designation right in Section 2.1(d) of the Settlement

Agreement.

6. Within three business days of the Effective Date, the parties shall

file a joint stipulation of dismissal of the Declaratory Judgment Action and

Turnover Action with prejudice based on this Order.

7. The following claims are subordinated to all other allowed claims in

the Bankruptcy Case, but shall remain senior in priority to any equity interests

in the Debtor:

i. any legal fees awarded by the Bankruptcy Court to the

Stimwave Parties or the KLIM Parties pursuant to ECF #135,

136, 157, 163, or 174;

ii. Stimwave Parent’s Claim No. 18-1 in the amount of $67,929.07;

iii. Stimwave Parent’s Claim No. 19-2 in the amount of

$3,772,073.00;

iv. Stimwave Parent’s Claim No. 20-2 in the amount of

$3,042,158.28.

v. KLIM’s Claim No. 22-3 in the amount of $21,193,481.45; and

vi. KLIM’s Claim No. 23-1.

The Trustee shall have a right to object to any of these claims other

than the claims described in paragraph 7.i.

8. Effective as of the Effective Date, the Debtor Releasing Parties, the

Stimwave Releasing Parties and the KLIM Releasing Parties are permanently

enjoined and barred from pursuing, commencing or continuing in any manner

any action or other proceeding of any kind on account of any Causes of Action

that are released pursuant to the releases set forth in Section 3.1 of the

Settlement Agreement, as applicable.

9. The Debtor and any interested party purporting to act on behalf of

the Debtor are hereby enjoined from taking any action (or failing to take any

action) in violation or contravention of Sections 4.3 and 4.5 of the Settlement

Agreement. This injunction applies to all interested parties that received notice

of the 9019 Motion and this Order. However, nothing in this Order shall be

interpreted as an injunction against any person who is not the Debtor or a party

purporting to act on behalf of the Debtor. The Stimwave Parties and the KLIM

Parties will have the right to pursue any other parties not falling within the

description of the preceding sentence for injunctive or other relief in whatever

fora are available under non-bankruptcy law.26

10. Any automatic stay in this case in favor of or for the benefit of Debtor

or any of its employees or Affiliates shall be lifted in favor of the Stimwave Parties

26 It appears that Section 4.1(d) of the Settlement Agreement could be interpreted to enjoin

parties other than the Debtor and non-Debtor parties purporting to act on behalf of the Debtor.

At the Evidentiary Hearing the Court expressly raised concerns about whether the Movants took

the position that the Settlement Agreement would enjoin non-Debtor parties. In fact, at some

point during the hearing on May 7, 2020 the Court observed that approval of the 9019 Motion

would apparently mean that the litigation would probably continue with respect to any alleged

use by MMC of the assets subject of the Transfer Agreements. Counsel for KLIM, on behalf of the

Movants, specifically stated that the Movants were not asking this Court to impose an injunction

against non-Debtor parties. But notwithstanding that this Order will not act as an injunction of

non-Debtor parties other than those purporting to act on behalf of the Debtor, and for the

avoidance of doubt, MMC, the former employees who raised objections, and Ms. Perryman, as

well as all other parties in interest who received notice, had the opportunity to participate in the

Evidentiary Hearing and to raise objections to the admission of evidence, cross-examine the

Movants’ witnesses, and present their own evidence to contradict the evidence that forms the

basis for this Court’s findings of fact and conclusions of law. The fact that some chose not to do

so does not mean they are not bound by the findings of this Court set forth in this Order; they

are.

and KLIM Parties to expressly authorize the Stimwave Parties and/or the KLIM

Parties to provide written notice to any employee, agent, or other representative

of the Debtor or anyone else purporting to act on behalf of the Debtor (i) to

immediately cease (a) any development, manufacture, marketing, sales,

commercial distribution or clinical trials of any Pain Product by Debtor, or any

other entity acting on behalf of the Debtor, including Micron Medical Delaware,

Micron Medical Florida, or any other Person acting on behalf of the Debtor, and

(b) any development, manufacture, marketing, sales, commercial distribution or

clinical trials of any Pain Product on behalf of the Debtor or provide services on

behalf of the Debtor to or otherwise assist or support any Affiliate of Debtor on

behalf of the Debtor, including Micron Medical Delaware, Micron Medical Florida,

Laura Perryman, Patrick Larson, or any other employee or former employee of

Debtor or any of its Affiliates, or any other Person, in the development,

manufacture, marketing, sales, commercial distribution or clinical trials of any

pain relief product or system, or method, including without limitation the Pain

Product or any other PNS wireless neurostimulator; and (ii) otherwise to proceed

with, initiate or pursue any claim, demand, or Cause of Action against any Non-

Released Parties.

11. The Trustee, Stimwave, and KLIM are authorized to take any and all

action necessary to effectuate the Settlement Agreement.

12. The effect of this Order shall survive the conversion, dismissal

and/or closing of the Debtor’s chapter 11 case, appointment of a chapter 11

trustee, and/or confirmation of a plan of reorganization or liquidation.

13. The Court reserves sole and exclusive jurisdiction to interpret and

enforce the terms of this Order and the Settlement Agreement between the

parties and to enter further orders as necessary to implement the Settlement

Agreement.

14. The Settlement Agreement shall include the following modifications:

i. A new section 4.9 of the Settlement Agreement shall provide as

follows: The Stimwave Parties agree to and shall indemnify the

Debtor’s estate in an amount up to $180,000 for any claims

allowed by a final order of the Bankruptcy Court arising from

the rejection of that certain Distribution Agreement between the

Debtor and Miami Medtech, LLC. Stimwave is granted and shall

retain sole authority to litigate or settle any claim with Miami

Medtech, LLC on behalf of the Debtor’s estate.

ii. The definition of “Retained Claims” in Article I, Section 1.1 of the

Settlement Agreement shall be modified to provide as follows:

“Retained Claims” means any Cause of Action of the Debtor (i)

that the Debtor has against any licensed professional for

professional negligence arising out of services performed for the

Debtor; (ii) that are prohibited from being assigned under

applicable law; or (iii) to enforce the terms of this Agreement or

the Ancillary Agreements; provided, that for the avoidance of

doubt, Retained Claims shall include any Cause of Action

pursuant to chapter 5 of the Bankruptcy Code other than (x)

Causes of Action involving turnover provisions of Bankruptcy

Code sections 542 and 543 and (y) Causes of Action against the

Stimwave Released Parties and KLIM Released Parties.

###

Copies to:

Marc Barmat, Esq.

Julia Kefalinos, Esq.

Eyal Berger, Esq.

Patricia Redmond, Esq.

Adam Skolnik, Esq.

Attorney Barmat is directed to serve a copy of this Order on interested parties who do not

receive service by CM/ECF, and file a proof of such service within two (2) business days from entry

of the Order.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.